Home/Filings/4/0001140361-15-045407
4//SEC Filing

PROVECTUS BIOPHARMACEUTICALS, INC. 4

Accession 0001140361-15-045407

$PVCTCIK 0000315545operating

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 8:01 PM ET

Size

8.3 KB

Accession

0001140361-15-045407

Insider Transaction Report

Form 4
Period: 2015-12-21
WACHTER ERIC PHD
DirectorVice President Pharmaceuticals
Transactions
  • Exercise/Conversion

    Common Stock

    2015-12-21$1.02/sh+120,000$122,4005,513,236 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2015-12-21120,000120,000 total
    Exercise: $1.02From: 2006-06-23Exp: 2016-06-23Common Stock (120,000 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    824,248
  • Common Stock

    (indirect: By Trust)
    4,867

Documents

1 file

Issuer

PROVECTUS BIOPHARMACEUTICALS, INC.

CIK 0000315545

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000315545

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 8:01 PM ET
Size
8.3 KB